Skip to main navigation
Company Logo
  • About
    • About Overview
    • Leadership
    • Careers
  • Product
    • RECELLĀ® System
  • Clinical Development
    • Pipeline/Clinical Trials
    • Patient Outcomes
    • Proof Assets
  • News & Media
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Annual Reports & Proxy
    • Stock Information
    • Corporate Governance
    • FAQ
    • Email Alerts
    • Contact
  • Contact
  • Search
  • Overview
  • Press Releases
  • Events & Presentations
  • Financials
  • Annual Reports & Proxy
  • Stock Information
  • Corporate Governance
  • FAQ
  • Email Alerts
  • Contact
global

Investors: SEC Filing Details

Document Details

Form
8-K/A
Filing Date
May 16, 2023
Document Date
May 11, 2023
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
AVITA Medical, Inc.
Issuer
AVITA MEDICAL, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
AVITA Medical, Inc. Logo with tag

Contact Investor Relations

Jessica Ekeberg
Director, Investor Relations
investor@avitamedical.com

Request Email Alerts
® 2023 AVITA Medical, Inc.
  • Terms of Use
  • Privacy Policy
  • CA Compliance
  • Social Media
  • CCPA
  • Compliance and Ethics
  • Important Safety Information

Social Media

  • Twitter (opens in new window)
  • Linkedin (opens in new window)